Dietary supplements’ role in health care remains prominent
WHAT IT MEANS AND WHY IT’S IMPORTANT In the past three years, the CRN Foundation has interviewed a broad swathe of healthcare professionals around both their personal and professional use/recommendation of dietary supplements. Two years ago, the majority of physicians and nurses recommended the use of dietary supplements; last year orthopedic specialists, cardiologists and dermatologists each testified to the inherent value of supplements.
(THE NEWS: Study finds most nurse practitioners recommend dietary supplements to patients. For the full story, click here)
Incidentally, this confirms what we at Drug Store News and our sister publication at Retail Clinician have known for quite some time, according to the 2009 Retail Clinician reader survey, more than 66% of nurse practitioners report they regularly talk to their patients about dietary supplements.
Currently, supplement manufacturers are no where in terms of engaging the in-store nurse practitioner. These results suggest suppliers in this space need to be thinking beyond just the consumer at the shelf — what about the patient in the clinic? What is your brand doing to help that NP help her clinic own that patient relationship? Where does it fit in?
Target names new board member
MINNEAPOLIS Target announced that chairman, president and CEO John Stumpf of Wells Fargo & Co. has been appointed to its board of directors, effective immediately. Stumpf will replace George Tamke, who retired from the board on March 9.
Stumpf is a 28-year veteran at Wells Fargo, having joined the former Norwest Corp. (predecessor of Wells Fargo) in 1982. He was named CEO in June 2007, elected to Wells Fargo’s board of directors in June 2006, and has been president since August 2005.
George Tamke has served on Target’s board since 1999. He is a partner at Clayton, Dubilier, & Rice, a private investment firm.
Target also announced that Richard Kovacevich, former chairman and CEO of Wells Fargo & Co., intends to retire from Target’s board of directors on Dec. 31. Kovacevich has served on Target’s board since 1996.
CVS Caremark declares quarterly dividend
WOONSOCKET, R.I. CVS Caremark’s board of directors has approved a quarterly dividend of $0.0875 per share on the common stock of the corporation, payable May 4 to holders of record on April 23.